{"id":"NCT00478231","sponsor":"ViiV Healthcare","briefTitle":"Multicenter, Safety Study Of Maraviroc","officialTitle":"A Multicenter, Open Label, Non-Comparative Safety Study Of Maraviroc","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2010-08","completion":"2010-09","firstPosted":"2007-05-24","resultsPosted":"2011-08-08","lastUpdate":"2011-09-09"},"enrollment":209,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acquired Immunodeficiency Syndrome","HIV Infection"],"interventions":[{"type":"DRUG","name":"Maraviroc","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"To collect safety and tolerability data in a more diverse patient population of patients with HIV/Aids, who have limited therapeutic options.","primaryOutcome":{"measure":"Number of Participants With Grade 3 and Grade 4 Adverse Events (AEs) and Serious Adverse Events (SAEs)","timeFrame":"Baseline to 30 days post-week 96 or early termination (ET)","effectByArm":[{"arm":"Maraviroc","deltaMin":40,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":16,"countries":["Brazil"]},"refs":{"pmids":["23731330"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A4001063&StudyName=Multicenter%2C%20Safety%20Study%20Of%20Maraviroc"]},"adverseEventsSummary":{"seriousAny":{"events":34,"n":206},"commonTop":["Diarrhoea","Nasopharyngitis","Headache","Subcutaneous nodule","Sinusitis"]}}